Aerie's Netarsudil Headed For Broad Indication With Only Subpopulation Efficacy
US FDA's Dermatologic and Ophthalmologic Drugs Advisory Committee votes in favor of efficacy of proposed glaucoma treatment, but several say only in patients with baseline intraocular pressure less than 25 mmHg.
